NCT01170351View on ClinicalTrials.gov

Cyclosporine-A Versus Prednisolone for Induction of Remission in Auto-immune Hepatitis

PHASE3CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2018

Conditions
Autoimmune Hepatitis
Interventions
DRUG

Cyclosporine-A

Cyclosprorine-A will be administered to patients in group-B according to a set protocol and the patients will be followed at regular intervals with appropriate checking of clinical and para-clinical data.

Trial Locations (1)

14117

Digestive Disease Research Center, Shariati Hospital, Tehran

All Listed Sponsors
lead

Tehran University of Medical Sciences

OTHER

NCT01170351 - Cyclosporine-A Versus Prednisolone for Induction of Remission in Auto-immune Hepatitis | Biotech Hunter | Biotech Hunter